Share-based Compensation (Tables)

12 Months Ended

Dec. 31, 2022

Share-Based Payment Arrangement [Abstract]

Summary of consolidated stock-based compensation expense, by type of awards

	For the Years Ended
	December 31,		December 31,
	2022		2021
Employee stock options	$	3,095	$	4,593
Restricted share grants		623		1,196
Total share-based compensation expense	$	3,718	$	5,789

Summary of consolidated stock-based compensation by line items

	For the Years Ended
	December 31, 2022		December 31, 2021
General and administrative	$	3,700	$	5,771
Sales, marketing and customer service		18		18
Total share-based compensation expense, net of nil income taxes	$	3,718	$	5,789

Summary of assumptions used in the determination of the fair value of share-based payment awards using the Black-Scholes model for stock option grants

	For the Years Ended
	December 31, 2022		December 31, 2021
Expected term		–		6.25 years
Risk-free interest rate		–		0.11%-0.16%
Expected volatility		–		713%-719%
Expected dividend yield		–		0%

(b)       2021 Equity Incentive Plan of Phoenix

	For the Years Ended
	December 31, 2022		December 31, 2021
Expected term		6.25 years		1-3 years
Risk-free interest rate		3.04%-3.97%		1.52%
Expected volatility		137.7% - 169.3%		64.4% - 69.0%
Expected dividend yield		0%		0%

(c)        2021 SolarJuice Equity Incentive Plan

	For the Years Ended
	December 31, 2022		December 31, 2021
Expected term		6.25 years		3 years
Risk-free interest rate		2.94% - 3.93%		1.52%
Expected volatility		73.54% - 74.17%		45.3%
Expected dividend yield		0%		0%

Summary of stock option activities

	Shares			Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Term		Aggregate Intrinsic Value ($000)
Outstanding as of December 31, 2020		388,900			10		7.52	$	486
Granted		969,000			7
Exercised		(25,000	)		4
Forfeited/expired		(117,000	)		11
Outstanding as of December 31, 2021		1,215,900			8		9.04	$	82
Granted		–			–
Exercised		–			–
Forfeited/expired		–			–
Outstanding as of December 31, 2022		1,215,900			7		7.87		1
Exercisable as of December 31, 2022		440,150			6		7.35	$	1
Non-vested as of December 31, 2022		775,750			7

Summary of exercise price and remaining life information about options exercisable

Range of exercise price	Shares Exercisable		Weighted Average Remaining Contractual Life		Weighted Average Exercise Price		Aggregate Intrinsic ($000)
$118 - $172		1,000		2.08	$	172.00		–
$40 - $117		14,600		3.33	$	62.03		–
$3 - $39		412,050		7.52	$	7.54		–
$1-$2		12,500		6.80	$	1.61		1
		440,150		7.35		6.36		1

Summary of restricted stock awards

	Number of Shares			Weighted Average Grant-Date Fair Value
Restricted stock units at December 31, 2020		–			–
Granted		184,000		$	6.34
Vested		(184,000	)	$	6.34
Restricted stock units at December 31, 2021		–			–
Granted		229,888		$	2.71
Vested		(229,888	)	$	2.71
Restricted stock units at December 31, 2022		–			–

Schedule of Phoenix's stock option activities

	Shares			Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Term		Aggregate Intrinsic Value ($000)
Outstanding as of December 31, 2020		–			–		–	$	–
Granted		2,040,500		$	1.72
Exercised		–
Forfeited/expired		(354,000	)	$	1.72
Outstanding as of December 31, 2021		1,686,500		$	1.72		9.45	$	2,091
Granted		888,000			1.70
Exercised		(80,625	)
Forfeited/expired		(731,375	)		1.72
Outstanding as of December 31, 2022		1,762,500			1.71		8.93		16
Exercisable as of December 31, 2022		212,063			1.63		8.25		12
Expected to vest as of December 31, 2022		1,550,437		$	1.72

Schedule of SJ group stock option activities

	Shares			Weighted- Average Exercise Price Per Share		Weighted-Average Remaining Contractual Term		Aggregate Intrinsic Value ($000)
Outstanding as of December 31, 2020		–			–		–	$	–
Granted		1,529,290		$	1.92
Exercised		–
Forfeited/expired		(413,215	)	$	1.92
Outstanding as of December 31, 2021		1,116,075		$	1.92		9.44	$	1,607
Granted		378,752			3.56
Exercised		–
Forfeited/expired		(450,179	)		1.92
Outstanding as of December 31, 2022		1,044,648			2.51		8.80		3,861
Vested and exercisable as of December 31, 2022		166,474			1.92		8.36		694
Non-vested as of December 31, 2022		878,174		$	2.63